AVR 0.38% $13.15 anteris technologies ltd

Ann: Investor presentation, page-97

  1. 3,010 Posts.
    lightbulb Created with Sketch. 1837
    Hi Tommy,

    With respect, comparing the past to now is like chalk and cheese for too many reasons to list here. And my time is too valuable.

    Wayne has given his forecast so even if you asked him what is he going to say? By giving the forecast in black and white he is saying he will achieve it. That’s all the assurance I need.

    I am not sure what else one could want?

    Now that does not mean it’s a guarantee as it is a future forecast. However, Wayne is in the drivers seat and knows exactly what is happening with the company and what can be achieved. So by investing in Admedus I am investing in Wayne (and Adapt) and his team and their ability to deliver.

    That is no different to any other investment except this time we have very clear yardsticks with which to measure performance. So many companies with much higher MC’s than ours give zero guidance, that’s if they even make revenue.

    I would have thought that my last few posts clearly articulate why we are on the cusp of finally achieving what many believed we should have been able to achieve years ago.

    However, a brief recap of the main points won’t hurt (apart from my time).

    * We now have a unique product in 3D that no one else has. If you want to do an arch repair ther is NO other viable choice compared to 3D.

    * We now have world renowned surgeons advising us on our 3D product pipeline (they talk to many other doctors).

    * We are now generating interest from surgeons as they hear about 3D (think halo effect.)

    * 3D is a high value high margin product. You would have to sell about 14 VC’s just to equal one 3D and for less profit.

    * We are expanding 3D into other countries. India next??? Currently in US and Canada.

    * We have the highest number of highest qualified reps in our history.

    * Europe is turning around under new leadership.

    * We have secured a GPO (Group Purchasing Organisation) with 80% compliance opening up 1500 hospitals with the only other competitor a poor alternative.

    * We now have 4 products on the market.

    * 10 year clinical data

    * DSD has been with Admedus a mere 10 months and now has a team he is happy with. Wayne has been permanent CEO now for 12 months.

    So while our performance in the past has been slower than expected (hence our SP) our current and future position looks very very different. With another high value 3D product to be commercialised this year we are in excellent shape.

    So again, all of this does not gaurantee that we will hit our Q2 targets but at least it helps to explain how we might get there. I for one would rather have the targets as it really holds management accountable and I know given our history Wayne will not want to stuff this up. So again I won’t question the bus driver who knows the way to reach our destination. As a passenger I can only trust that he has been there before, knows the way and can drive the bus better than me.

    I do find it amusing though that in the early days everyone “expected” this type of growth and then was very disappointed with the company when it failed to materialise (all the hope, focus and funds where on AI).

    Now all of that has changed and we are finally doing what we should have done years ago and few (including the general market) can believe it. A case of show me the money maybe.

    So again, I am not sure what more assurances you can get at this stage from Wayne as to me he has clearly made his targets and expectations known. Just over 3 months and all will be revealed.

    DYOR and Not advice.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.